The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions, And Smid-Cap Earnings

Biotech stocks advanced in the week ended August 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus treatment/vaccine news flow supported the move to the upside.